Antonio Pellegrino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Antonio Pellegrino has a total of 223 co-authors. Here are the top co-authors by number of shared publications:
- Gianluca Raffaello Damiani
Department of Biomedical and Human Oncological Science (DIMO), University of Bari, Policlinico of Bari, Bari, Italy
26 shared publications - Fabio Landoni
Department of Medicine and Surgery, University of Milan-Bicocca, 20126 Milan, Italy
12 shared publications - Gennaro Cormio
Gynecologic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy
12 shared publications Costantino Mangioni
A Department of Obstetrics and Gynecology , Alessandro Manzoni Hospital , Lecco , Italy
8 shared publications- Robert Fruscio
Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy
7 shared publications - Giuseppe Loverro
School of Medicine, University of Bari
6 shared publications
Latest Publications
- 1 June 2017
- Published by Edizioni Minerva Medica in Minerva Obstetrics and Gynecology
- Vol. 69 (4) , 402-404
Outcomes of vaginal lipofilling with the tumescent technique
Article: Outcomes of vaginal lipofilling with the tumescent technique - Minerva Ginecologica 2017 August;69(4):402-4 - Minerva Medica - Journals
- 1 June 2017
- Published by Edizioni Minerva Medica in Minerva Obstetrics and Gynecology
- Vol. 69 (4) , 402-404
Outcomes of vaginal lipofilling with the tumescent technique
Article: Outcomes of vaginal lipofilling with the tumescent technique - Minerva Ginecologica 2017 August;69(4):402-4 - Minerva Medica - Journals
- 1 January 2017
- Published by Edizioni Minerva Medica in Minerva Obstetrics and Gynecology
- Vol. 69 (1) , 13-17
Robotic sacrocolpopexy for posthysterectomy vaginal vault prolapse: a case series of 31 patients by a single surgeon with a long term follow-up
Article: Robotic sacrocolpopexy for posthysterectomy vaginal vault prolapse: a case series of 31 patients by a single surgeon with a long term follow-up - Minerva Ginecologica 2017 February;69(1):13-7 - Minerva Medica - Journals
- 1 January 2017
- Published by Edizioni Minerva Medica in Minerva Obstetrics and Gynecology
- Vol. 69 (1) , 13-17
Robotic sacrocolpopexy for posthysterectomy vaginal vault prolapse: a case series of 31 patients by a single surgeon with a long term follow-up
Article: Robotic sacrocolpopexy for posthysterectomy vaginal vault prolapse: a case series of 31 patients by a single surgeon with a long term follow-up - Minerva Ginecologica 2017 February;69(1):13-7 - Minerva Medica - Journals
- 26 July 2016
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 11 (2) , 115-121
Cost analysis of minimally invasive hysterectomy vs open approach performed by a single surgeon in an Italian center
Despite the rapid uptake of robotic surgery, the effectiveness of robotically assisted hysterectomy (RAH) remains uncertain, due to the costs widely variable. Observed the different related costs of robotic procedures, in different countries, we performed a detailed economic analysis of the cost of RAH compared with total laparoscopic (TLH) and open hysterectomy (OH). The three surgical routes were matched according to age, BMI, and comorbidities. Hysterectomy costs were collected prospectively from September 2014 to September 2015. Direct costs were determined by examining the overall medical pathway for each type of intervention. Surgical procedure cost for RAH was €3598 compared with €912 for TLH and €1094 for OH. The cost of the robot-specific supplies was €2705 per intervention. When considering overall medical surgical care, the patient treatment average cost of a RAH was €4695 with a hospital stay (HS) of 2 days (range 2–4) compared with €2053 for TLH and €2846 for OH. The main driver of additional costs is disposable instruments of the robot, which is not compensated by the hospital room costs and by an experienced team staff. Implementation of strategies to reduce the cost of robotic instrumentation is due. No significant cost difference among the three procedures was observed; however, despite the optimal operative time, the experienced, surgeon and the lower HS, RAH resulted 2, 3 times and 1, 6 times more expensive in our institution than TLH and OH, respectively.
- 26 July 2016
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 11 (2) , 115-121
Cost analysis of minimally invasive hysterectomy vs open approach performed by a single surgeon in an Italian center
Despite the rapid uptake of robotic surgery, the effectiveness of robotically assisted hysterectomy (RAH) remains uncertain, due to the costs widely variable. Observed the different related costs of robotic procedures, in different countries, we performed a detailed economic analysis of the cost of RAH compared with total laparoscopic (TLH) and open hysterectomy (OH). The three surgical routes were matched according to age, BMI, and comorbidities. Hysterectomy costs were collected prospectively from September 2014 to September 2015. Direct costs were determined by examining the overall medical pathway for each type of intervention. Surgical procedure cost for RAH was €3598 compared with €912 for TLH and €1094 for OH. The cost of the robot-specific supplies was €2705 per intervention. When considering overall medical surgical care, the patient treatment average cost of a RAH was €4695 with a hospital stay (HS) of 2 days (range 2–4) compared with €2053 for TLH and €2846 for OH. The main driver of additional costs is disposable instruments of the robot, which is not compensated by the hospital room costs and by an experienced team staff. Implementation of strategies to reduce the cost of robotic instrumentation is due. No significant cost difference among the three procedures was observed; however, despite the optimal operative time, the experienced, surgeon and the lower HS, RAH resulted 2, 3 times and 1, 6 times more expensive in our institution than TLH and OH, respectively.
- 17 February 2016
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 55 (5) , 619-624
Outcomes of Bleomycin-based electrochemotherapy in patients with repeated loco-regional recurrences of vulvar cancer
Objective To evaluate the safety, local tumor efficacy and relief of symptoms of electrochemotherapy (ECT) treatment in patients affected by recurrence of vulvar cancer (VC), unsuitable for standard treatments. Methods Ten patients were recruited with histological diagnosis of recurrence of VC. Intravenous bleomycin was injected, after an accurate mapping of all lesions and ECT was performed. Response to therapy was evaluated and quality of life (QoL) was evaluated via questionnaires. Results Diagnosis stage of primary tumors, according to the FIGO system, was: four patients respectively at stage IB (40%), and at stage II (40%), one patient at stage IIIA (10%), one patient with Paget cancer (10%). Mean age was 76 years (SD ± 7) at time of enrollment. Eight patients (80%) were previously submitted to surgery and/or radio-chemotherapy. Mean treatment time was 20 (range 10–20) min. After a median follow-up of 12 (3–22) months, six patients (60%) were alive. Conclusions Objective responses (ORs) with local control of the tumor were obtained in 80%. After a mean follow-up of 12 (3–22) months six patients (60%) were alive. The favorable outcome of this study, indicates that ECT is a reliable treatment option that may improve their functioning, thus enhancing the care provided in the palliative setting.
- 17 February 2016
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 55 (5) , 619-624
Outcomes of Bleomycin-based electrochemotherapy in patients with repeated loco-regional recurrences of vulvar cancer
Objective To evaluate the safety, local tumor efficacy and relief of symptoms of electrochemotherapy (ECT) treatment in patients affected by recurrence of vulvar cancer (VC), unsuitable for standard treatments. Methods Ten patients were recruited with histological diagnosis of recurrence of VC. Intravenous bleomycin was injected, after an accurate mapping of all lesions and ECT was performed. Response to therapy was evaluated and quality of life (QoL) was evaluated via questionnaires. Results Diagnosis stage of primary tumors, according to the FIGO system, was: four patients respectively at stage IB (40%), and at stage II (40%), one patient at stage IIIA (10%), one patient with Paget cancer (10%). Mean age was 76 years (SD ± 7) at time of enrollment. Eight patients (80%) were previously submitted to surgery and/or radio-chemotherapy. Mean treatment time was 20 (range 10–20) min. After a median follow-up of 12 (3–22) months, six patients (60%) were alive. Conclusions Objective responses (ORs) with local control of the tumor were obtained in 80%. After a mean follow-up of 12 (3–22) months six patients (60%) were alive. The favorable outcome of this study, indicates that ECT is a reliable treatment option that may improve their functioning, thus enhancing the care provided in the palliative setting.
- Open Access
- 1 February 2016
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 55 (1) , 145-146
A rare case of pure uterine giant lipoma
- 1 February 2016
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 55 (1) , 145-146
Open AccessA rare case of pure uterine giant lipoma
- 1 November 2015
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 22 (7) , 1287-1292
Robotic Shaving Technique in 25 Patients Affected by Deep Infiltrating Endometriosis of the Rectovaginal Space
- 1 November 2015
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 22 (7) , 1287-1292
Robotic Shaving Technique in 25 Patients Affected by Deep Infiltrating Endometriosis of the Rectovaginal Space
- 12 October 2015
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 36 (3) , 410-415
Conventional fascial technique versus mesh repair for advanced pelvic organ prolapse: Analysis of recurrences in treated and untreated compartments
117 women with severe pelvic organ prolapse (POP; stage > 2) were enrolled to elucidate a 24-month outcome of POP surgery, using conventional or mesh repair with 3 techniques. 59 patients underwent conventional repair and 58 underwent mesh repair. Two types of mesh were used: a trocar-guided transobturator polypropylene (Avaulta, Bard Inc.) and a porcine dermis mesh (Pelvisoft, Bard Inc.). Women with recurrences, who underwent previous unsuccessful conventional repair, were randomised. Primary outcome was the evaluation of anatomic failures (prolapse stage > 1) in treated and untreated compartments. Anatomic failure was observed in 11 of 58 patients (19%; CI 8.9–29) in the mesh group and in 16 of 59 patients (27.1%; p value = 0.3) in the conventional group. 9 of 11 failures in the mesh group (15.5%; CI 6.2–24.8) were observed in the untreated compartment (de novo recurrences), 14.3% in Pelvisoft and 16.7% in Avaulta arm, while only 1 recurrence in the untreated compartment (1.7%) was observed in the conventional group (odds ratio 10.6, p = 0.03).
- 12 October 2015
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 36 (3) , 410-415
Conventional fascial technique versus mesh repair for advanced pelvic organ prolapse: Analysis of recurrences in treated and untreated compartments
117 women with severe pelvic organ prolapse (POP; stage > 2) were enrolled to elucidate a 24-month outcome of POP surgery, using conventional or mesh repair with 3 techniques. 59 patients underwent conventional repair and 58 underwent mesh repair. Two types of mesh were used: a trocar-guided transobturator polypropylene (Avaulta, Bard Inc.) and a porcine dermis mesh (Pelvisoft, Bard Inc.). Women with recurrences, who underwent previous unsuccessful conventional repair, were randomised. Primary outcome was the evaluation of anatomic failures (prolapse stage > 1) in treated and untreated compartments. Anatomic failure was observed in 11 of 58 patients (19%; CI 8.9–29) in the mesh group and in 16 of 59 patients (27.1%; p value = 0.3) in the conventional group. 9 of 11 failures in the mesh group (15.5%; CI 6.2–24.8) were observed in the untreated compartment (de novo recurrences), 14.3% in Pelvisoft and 16.7% in Avaulta arm, while only 1 recurrence in the untreated compartment (1.7%) was observed in the conventional group (odds ratio 10.6, p = 0.03).
- 12 October 2015
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 36 (3) , 390-392
Diagnosis and management of a rare case of fetal mediastinal teratoma without non-immunological hydrops
- 12 October 2015
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 36 (3) , 390-392
Diagnosis and management of a rare case of fetal mediastinal teratoma without non-immunological hydrops
- 1 August 2015
- Vol. 67 (4) , 386-7
Acute spinal cord compression in the third trimester of pregnancy.